Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $2.2 Million - $2.53 Million
27,300 New
27,300 $2.33 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $776,064 - $858,720
9,600 New
9,600 $817,000
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $878,814 - $1.03 Million
11,900 Added 195.08%
18,000 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $386,130 - $479,826
6,100 New
6,100 $452,000
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $4,927 - $6,608
-100 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$43.77 - $63.22 $4,377 - $6,322
-100 Reduced 50.0%
100 $6,000
Q4 2021

Feb 14, 2022

BUY
$49.55 - $74.59 $9,910 - $14,918
200 New
200 $11,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.